Jylamvo contains 2mg of methotrexate per mL and is packaged in bottles containing 60mL of oral solution. Each pack contains 1 bottle and a dosing syringe to ensure proper dosing.

The FDA has expanded the approval of an oral liquid methotrexate solution to include children and adolescents with polyarticular juvenile idiopathic arthritis and acute lymphoblastic leukemia ...

About JYLAMVO ™. JYLAMVO is an anti-inflammatory and cancer oral methotrexate solution approved by the U.S. Food and Drug Administration for use in adult and pediatric patients with ...